WHO report reveals increasing antimicrobial resistance in bacterial infections
The report includes an innovative interactive digital format to facilitate data extraction and graphics.
Stay updated with breaking news from Acinetobacter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The report includes an innovative interactive digital format to facilitate data extraction and graphics.
In a new study, researchers investigated Acinetobacter species bloodstream infection (BSI) case counts from a subset of laboratory data continuously reported during the initial two years of SARS-CoV-2 infections, i.e., from 2020 to 2021.
Using bacteria of the Bartonella henselae species, researchers from Goethe University, Frankfurt University Hospital, the Paul Ehrlich Federal Institute for Vaccines and Biomedicines in Langen, and the University of Oslo demonstrated for the first time that antibodies can prevent certain surface proteins of bacterial pathogens from entering host cells.
A recent study reports the development of a synthetic antibacterial peptide PLG0206.
Acinetobacter baumannii is a bacterial pathogen responsible for serious hospital-related infections that is becoming increasingly resistant against antibiotics.